Quince Therapeutics, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Quince Therapeutics, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2017 to Q4 2023.
  • Quince Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $4.34M, a 17.7% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $4.34M +$651K +17.7% Dec 31, 2023 10-K 2024-04-01
Q4 2022 $3.69M +$439K +13.5% Dec 31, 2022 10-K 2024-04-01
Q4 2021 $3.25M +$1.27M +64.4% Dec 31, 2021 10-K 2024-04-01
Q4 2020 $1.98M +$917K +86.6% Dec 31, 2020 10-K 2023-03-15
Q4 2019 $1.06M +$703K +197% Dec 31, 2019 10-K 2022-03-01
Q4 2018 $356K +$185K +108% Dec 31, 2018 10-K 2022-03-01
Q4 2017 $171K Dec 31, 2017 10-K 2021-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.